Divalproex Sodium
NDC 68001-472, Divalproex Sodium, tablet, delayed release, from BluePoint Laboratories.
- Product NDC
- 68001-472
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079163
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIVALPROEX SODIUM125 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-472-00 | 68001047200 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (68001-472-00) |
| 68001-472-03 | 68001047203 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (68001-472-03) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b95494e2-ee7a-7415-e053-2995a90ae852NADAC price for package 68001047200
GET /v1/drugs/nadac/68001047200NADAC price for package 68001047203
GET /v1/drugs/nadac/68001047203
Use it
Look up 68001-472 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-472. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.